Sernova, Seraxis sign definitive merger agreement
Sernova Biotherapeutics and Seraxis Holdings announced a definitive agreement to combine their technologies and businesses into BetaNova Biotherapeutics, a clinical-stage type 1 diabetes islet cell-replacement company.